Synthesis, luminescent properties and antibacterial activity of new pyrazoline and pyrimidine derivatives of (2e)-1-biphenyl-3-arylprop-2-en-1-ones

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Substituted prop-2-en-1-ones were obtained by the condensation reaction of 1-biphenyl-4-yl-ethanone with aromatic aldehydes in the presence of sodium hydroxide in an aqueous ethanol solution. Subsequent cyclization of the latter with hydrazine hydrate, phenylhydrazine, and thiosemicarbazide in an acidic medium leads to the corresponding pyrazolines. The reaction of amidine hydrochlorides with chalcones in a KOH-ethanol system leads to 2,4,6-trisubstituted pyrimidines. The luminescent and antibacterial properties of the resulting systems was studied.

Sobre autores

A. Isakhanyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

Email: anush.isakhanyan.51@mail.ru

N. Hakobyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

Z. Hovasyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

G. Grigoryan

Yerevan State University

R. Mkhitaryan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

H. Aracelyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

A. Safaryan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

R. Muradyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

H. Panosyan

Scientific and Technological Center of Organic and Pharmaceutical Chemistry of the National Academy of Sciences of the Republic of Armenia

Bibliografia

  1. Li J.-T., Zhang X.-H., Lin Z.-P. // Beilstein J. Org. Chem. 2007. Vol. 3. N 13. doi: 10.1186/1860-5397-3-13
  2. Li Q.S., Shen B.N., Zhang Z., Luo S., Ruan B.F. // Curr. Med. Chem. 2021. Vol. 28. N 5. P. 940. doi: 10.2174/0929867327666200306120151
  3. Patil S.B. // Int. J. Pharm. Sci. Res. 2018. Vol. 9. N 1. P. 44. doi: 10.13040/IJPSR.0975-8232.9(1).44-52
  4. Elkanzi N.A.A. // Orient. J. Chem. 2020. Vol. 36. N 6. P. 1001. doi: 10.13005/ojc/360602
  5. Sviripa V.M., Zhang W., Balia A.G., Tsodikov O.V., Nickell J.R., Gizard F., Yu T., Lee E.Y., Dwoskin L.P., Watt D.S. // J. Med. Chem. 2014. Vol. 57. P. 6083. doi: 10.1021/jm5004864
  6. Varghese B., Al-Busafi S.N., Suliman F.O., AlKindy S.M.Z. // RSC Adv. 2017. Vol. 7. P. 46999. doi: 10.1039/C7RA08939B
  7. Selivanova D.G., Gorbunov A.A., Mayorova O.A., Vasyanin A.N., Lunegov I.V., Shklyaeva E.V., Abashev G.G. // Beilstein J. Org. Chem. 2017. Vol. 13. P. 1583. doi: 10.3762/bjoc.13.158.
  8. Achelle S., Rodríguez-Lopez J., Larbani M., Plaza-Pedroche R., Robin-le Guen F. // Molecules. 2019. Vol. 24. P. 1742. doi: 10.3390/molecules24091742
  9. Shivananda M.K., Holla B.S. // J. Chem. Pharm. Res. 2017. Vol. 9. N 6. P. 1.
  10. Руководство по проведению доклинических исследований лекарственных средств / Под ред. А.Н. Миронова. М.: Медицина, 2012. С. 509.
  11. Машковский М.Д. Лекарственные средства. М.: Новая волна, 2010. С. 851.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Russian Academy of Sciences, 2023